Study first to link weed killer Roundup® to convulsions in animals
Roundup® to convulsions in animals A recent report by the United States Centers for Disease Control and Prevention found more than 80 percent of urine…
Category Research
Read More
Powerful new antibody neutralizes all known SARS-CoV-2 variants
As SARS- CoV- 2 has evolved and shifted, remedial antibodies that worked beforehand in the epidemic have come less effective, and newer variants, especially Omicron,…
Lynparza in combination with abiraterone granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer
First PARP asset to demonstrate clinical benefit in combination with a new hormonal agent irrespective of homologous recombination form( HRR) gene mutations AstraZeneca’s supplemental New…
New method of nasal vaccine delivery could lead to better vaccines for HIV and COVID-19
A University of Minnesota adjunct professor is part of a platoon that has developed a new way to effectively deliver vaccines through mucosal apkins in…
Research identifies, exploits vulnerability in certain high-risk cancers
In a study lately published in Cancer Research, a journal of the American Association for Cancer Research, a platoon of experimenters led byC. Patrick Reynolds,M.D.,Ph.D.,…
Scientists create long-acting injectable drug delivery system for tuberculosis
In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB…
Datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small cell lung cancer
Datopotamab deruxtecan- grounded combinations show promising clinical exertion in cases with advancednon-small cell lung cancerLate- breaking oral donation at WCLC features first results from TROPION-…
Tagrisso plus savolitinib demonstrated 49 objective response rate in lung cancer cases with high situations of MET overexpression and/ or modification in SAVANNAH Phase II trial
MET is the most common biomarker in cases with EGFR- shifted lung cancer who develop resistance to targeted remedyGlobal SAFFRON Phase III trial assessing this…
Treating cancer by sticking cells in place
Future treatments for advanced cancer could work by sticking cancer cells in place and preventing their spread around the body. A new study by researchers…
Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Based on DESTINY-Breast04 results which showed AstraZeneca and Daiichi Sankyo’s Enhertu reduced risk of disease progression or death by 50% and increased overall survival by…
Vitamin K prevents cell death: a new function for a long-known molecule
Vitamin K is well-known for its blood clotting and bone building properties but today a new study published in Nature reports on a novel function…
Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy
Pfizer Inc. (NYSE: PFE) today announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM, designed to evaluate the efficacy and safety…